Aaron Kilgallon

Aaron Kilgallon serves as an Honorary Fellow at the Frazer Institute, affiliated with The University of Queensland, where his research centers on cancer biology with emphasis on tumor microenvironment dynamics and immunotherapy efficacy.

His core research areas include Cancer Research, Immunotherapy, Tumor Microenvironment, Lung Cancer, Head and Neck Cancer, and Metabolomics. He utilizes advanced methodologies like multiplexed imaging and metabolic profiling to dissect spatial and biochemical features influencing cancer progression and treatment outcomes, particularly in solid tumors.

Analysis of his 2025 publications reveals a cohesive focus on leveraging tumor microenvironment characteristics—such as spatial architecture and metabolic/inflammatory niches—to predict immunotherapy responses and recurrence patterns in head and neck cancer and non-small cell lung cancer (NSCLC), highlighting translational applications for biomarker discovery.